Basal Cell Carcinoma — Trials

Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 16.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05929664	Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery	suspended	Phase 2	70	Thomas Jefferson UniversityOTHER	1	Jun 10, 2026	clinicaltrials
NCT00515970	Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas	suspended	N/A	400	University Hospital TuebingenOTHER	1	Jun 15, 2010	clinicaltrials